FINGOLIMOD SALTS Russian patent published in 2015 - IPC C07C215/28 C07C215/40 A61K31/137 A61K31/14 A61P37/06 A61P37/02 A61P29/00

Abstract RU 2543621 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to new 2-amino-2-[2-(4-C_2-20alkylphenyl)ethyl]propan-1,3-diol salts specified in tartrate, lactate benzoate, succinate, malonate, acetate and propionate in the crystalline form. Each of the above salts is characterised by powder X-ray pattern data. Compounds in the therapeutically effective amount can be used in treating autoimmune diseases.

EFFECT: crystalline salts of the present invention possess higher stability, better solubility, more convenient to store and handle.

11 cl, 7 dwg, 1 tbl, 10 ex

Similar patents RU2543621C2

Title	Year	Author	Number
CRYSTALLINE FORMS OF FINGOLIMOD HYDROCHLORIDE	2009	Mikhaehl' Mutts Guido Jordine	RU2549899C2
METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION	2010	Oomura Tomojuki Pudipeddi Madkhusudkhan Rojs Alan Ehduard Rjugger Kollin Sasaki Masaki Tamura Tokukhiro	RU2475236C2
PAEDIATRIC COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS	2009	Dzhon Kovarik Robert Shmouder Mari-Klod Bast'En Oliv'E David Geril Karlsson Tomas Bujon	RU2562571C2
ORAL PHARMACEUTICAL COMPOSITION	2010	Oomura Tomojuki Pudipeddi Madkhusudkhan Rojs Alan Ehduard Rjugger Kollin Sasaki Masaki Tamura Tokukhiro	RU2475237C2
DOSAGE FORMS, SALTS AND POLYMORPHS OF TRANSNORSERTRALINE AND USING THEM	2010	Laflin Sharon M. Sizenski Majkl Dzh. Singkh Surendra P. Uilkinson Skott Kh. Khuang Chaj Gu Bonejsija Filip Dzhejms D'Sauza Sjuzan S.	RU2578956C2
POLYMORPHIC FORMS OF MACROCYCLIC HCV INHIBITOR	2008	Stokbruks Sigrid Karl Marija Lejs Karina Suinni Kelli Ehnn Vujts Stejn Khorvat Andrash	RU2533830C2
ORGANIC COMPOUNDS	2004	Oomura Tomojuki Pudipeddi Madkhusudkhan Rojs Alan Ehduard Rjugger Kollin Sasaki Masaki Tamura Tokukhiro	RU2358716C2
7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2- [METHYL(METHYLSULFONYL)AMINO]PYRIMIDIN -5-YL]-(3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID CRYSTALLINE SALTS, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION	2001	Tehjlor Najdzhel Filip Okada Tetsuo	RU2265599C2
(1R,2R,4R*)-2-(2-{[3(4,7-DIMETHOXY-1H-BENZOIMIDAZOL-2-YL)PROPYL]METHYLAMINO}ETHYL)-5-PHENYLBICYCLO[2,2,2]OCT-5-EN-2-YL ISOBUTYRIC ACID SALTS	2009	Shtefan Abele Stefani Kombe Zhak-Aleksis Fjunel' Kurt Khil'Pert Fransis Juble Katarina Rajkhenbehkher Dorte Renneberg Markus Fon Raumer	RU2516247C2
CRYSTALLINE FORMS OF MAGL INHIBITOR	2017	Grajs, Sheril A. Dzhons, Todd K. Grimm, Kurt Dzh. Blankman, Zhaklin Lorejn Bils, Chenning Rodni	RU2799564C2

RU 2 543 621 C2

Authors

Mikhaehl' Mutts

Guido Jordine

Dates

2015-03-10—Published

2009-11-10—Filed